Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-09-10

FDA Approved: LORAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lorazepam from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)